Invention Grant
- Patent Title: Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
-
Application No.: US17004097Application Date: 2020-08-27
-
Publication No.: US11518765B2Publication Date: 2022-12-06
- Inventor: John Michael Southern , Stephen J. Connon
- Applicant: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
- Applicant Address: IE Dublin
- Assignee: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
- Current Assignee: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
- Current Assignee Address: IE Dublin
- Agency: Hoffman Warnick LLC
- Main IPC: A61P37/00
- IPC: A61P37/00 ; A61K31/519 ; C07D487/04 ; A61P37/02
Abstract:
The present invention describes compounds of formula (I) Wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S. These compounds have been identified as novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases.
Public/Granted literature
- US20210024529A1 SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES Public/Granted day:2021-01-28
Information query
